Circulating tumor cells count and characterization in a male breast cancer patient.

Cancer Biol Ther 2011 Sep 1;12(5):379-82. Epub 2011 Sep 1.

Department of Molecular Medicine,apienza University of Rome, Rome, Italy.

A 64-y-old man presented to Medical Oncology Department a metastatic invasive ductal breast carcinoma, positive for estrogen (ER) and progesterone receptors (PR) and Her2/neu negative. The patient was treated with different lines of therapy, with rapid radiological progression of disease. After four courses of a third-line chemotherapy, a radiological stable disease was maintained. The patient was followed by serial blood drawings for the characterization and count of circulating tumor cells (CTC). This is the first report concerning the predictive and prognostic value of CTC in a male breast cancer patient.

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.12.5.16304DOI Listing
September 2011
8 Reads

Publication Analysis

Top Keywords

cancer patient
8
breast cancer
8
tumor cells
8
circulating tumor
8
male breast
8
progression disease
4
radiological progression
4
courses third-line
4
chemotherapy radiological
4
third-line chemotherapy
4
rapid radiological
4
disease courses
4
therapy rapid
4
receptors her2/neu
4
progesterone receptors
4
estrogen progesterone
4
her2/neu negative
4
patient treated
4
lines therapy
4
treated lines
4

Similar Publications